The HEBE study is a multicentre trial that randomised @ patients with large first acute myocardial infarction ( AMI ) treated with primary percutaneous coronary intervention to either intracoronary infusion of bone marrow mononuclear cells ( BMMCs ) ( n = @ ) , peripheral blood mononuclear cells ( PBMCs ) ( n = @ ) or standard therapy ( n = @ ) .